利用药监数据来预测检查点抑制剂免疫疗法的人口规模毒性概况
Dongxue Yan1,2, Siqi Bao1,2, Zicheng Zhang1,2
1National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Nature computational science
|December 23, 2024
概括
一个新的深度学习框架,DySPred,准确地预测癌症患者的免疫检查点抑制剂 (ICI) 毒性,使用现实世界的数据. 该工具有助于主动监测和个性化治疗策略,以改善免疫治疗结果.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 药物监督 药物监督 药物监督
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了癌症免疫疗法,但与复杂的毒性有关.
- 预测和管理这些毒性仍然是临床结果和计算分析的重大挑战.
研究的目的:
- 引入DySPred,这是一个深度学习框架,用于预测ICI诱导的人口水平的毒性概况.
- 利用现实世界药物监测数据,在不同患者群体和癌症类型中进行准确的毒性风险评估.
主要方法:
- 开发DySPred,一个基于动态图卷积网络的深度学习框架.
- 利用大规模的真实世界药监数据进行模型培训和验证.
- 评估药物诱导的转录性改变与小分子抗瘤剂的毒性概况的一致性.
主要成果:
- DySPred准确地预测了各种人口群体和癌症类型的ICI毒性风险.
- 该框架在具有有限样本规模的场景中表现出弹性.
- DySPred揭示了ICI诱导毒性的时间趋势,并将毒性概况与转录数据对齐.
结论:
- DySPred提供了一种多功能方法,用于ICI诱导的毒性在人群层面进行分析.
- 该框架允许在癌症免疫治疗中进行主动的毒性监测和及时的治疗调整.
- 这种方法支持推进更安全,更有效的癌症免疫治疗策略.
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Analysis of Population Pharmacokinetic Data
224
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
224
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475


